Navigation Links
Amyris Chief Joins Renmatix BoD, New CFO Added to Company

KENNESAW, Ga., Sept. 14, 2011 /PRNewswire/ -- Renmatix, the leading producer of cellulosic sugars, is pleased to announce John Melo, CEO of renewable chemical and fuels company Amyris, has joined the Renmatix Board of Directors. Ellen Purdy, who last year was named "CFO of the Year" by the Philadelphia Business Journal, will fill the chief financial officer role as the company expands operations.

Melo comes to the Renmatix Board of Directors with rare perspective gained from launching one of the bioindustry's most watched companies. Melo began his career in energy markets at British Petroleum, where he most recently served as President of US Fuels Operations.

"Ask any of my colleagues in this bioindustry what they most need to succeed and they'll tell you: we need reliable sources of cost effective cellulosic sugar," said Melo. "Renmatix is delivering that sugar sustainably, with very attractive economics and taking the guesswork out of the bioindustrial supply chain."

Prior to joining Renmatix, Ellen Purdy served as CFO for SDI, serving the pharmaceutical and biotech markets. She brings more than a decade of chemical business experience to the company. Purdy's academic credentials include a B.S. from the Wharton School of Business at University of Pennsylvania, and an M.B.A. from Northwestern University.

"As a business person, I find Renmatix exciting because it's every bit as focused on economics as it is on technology," said Purdy. "I look forward to making the most of Renmatix's unique financial opportunities as we change the economics of cellulosic sugar."

Mike Hamilton, CEO of Renmatix, commented, "We are thrilled to have these two outstanding individuals join the Renmatix team. The additions position us for continued success and further reinforce our excitement in the company and the value Renmatix brings to the renewable materials business."

About Renmatix
Renmatix is the leading producer of cellulosic sugars for the global renewable chemical and fuels markets. The company's proprietary Plantrose™ process challenges conventional sugar economics by cheaply converting biomass – from woody biomass to agricultural residue – into useful, cost-effective sugars. Renmatix technology deconstructs non-food biomass an order of magnitude faster than other processes and enhances its cost advantage by using no significant consumables. Backed by Kleiner Perkins Caufield & Byers, Renmatix is privately held, with operations in Georgia currently capable of converting three dry tons of cellulosic biomass to sugar per day. For more information, please visit

Media contact:
Katie Struble
Antenna Group for Renmatix

SOURCE Renmatix
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
2. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
3. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
4. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
5. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
6. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
7. Algenol Biofuels Appoints Chief Science Officer
8. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
9. Chief Technology Officer Joins ACAMP
10. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
11. LS9, Inc. Appoints Bill Haywood Chief Executive Officer
Post Your Comments:
(Date:11/30/2015)... DIEGO , Nov. 30, 2015  HUYA Bioscience ... China,s pharmaceutical innovations, today announced it ... Drug Development Fund (KDDF) to foster collaboration between KDDF ... development and commercialization of healthcare products for the global ... as an important source of new innovative preclinical and ...
(Date:11/30/2015)... NORTH CHICAGO, Ill. , Nov. 30, 2015 /PRNewswire/ ... an all-inclusive program that focuses on a daily routine ... how patients take their medication can affect the way ... establish and follow to their a daily routine are ... is to help patients better manage their hypothyroidism ...
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... additional independent director, and the Company welcomes Neil ... in a recent anonymous internet report on NW Bio.  ... Linda Powers stated, "We agree with ...
(Date:11/30/2015)... and PETACH TIKVAH, Israel , Nov. ... BCLI ), a leading developer of adult stem cell ... Brainstorm Cell Therapeutics Ltd., has been awarded an additional grant ... of the Chief Scientist (OCS). This grant, the second this ... 2015 activities to approximately $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology:
(Date:11/20/2015)... 2015 NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... was recently interviewed on The RedChip Money Report ... weekend on Bloomberg Europe , Bloomberg Asia, Bloomberg ... NXTD ) ("NXT-ID" or the "Company"), a biometric ...
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific discoveries ... doctors and other healthcare providers face challenges in better ... and patients. In addition, as more children continue to ... patient,s adulthood and old age. John M. ... Children,s Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... Paris , qui ... Paris , qui s,est tenu du ... leader de l,innovation biométrique, a inventé le premier scanner ... sur la même surface de balayage. Jusqu,ici, deux scanners ... les empreintes digitales. Désormais, un seul scanner est en ...
Breaking Biology News(10 mins):